Science
Mechanism of Action
Acting as a cationic surface-active agent, this ingredient inhibits bacterial oxygen uptake, induces amino acid leakage, and damages bacterial cell surfaces. Its precise mechanism against diverse bacterial strains is under ongoing research.
Research
Clinical Evidence
Medium confidence0.15%
Key findings
- 01 Clinical application at 0.15% (1.5 mg/g) demonstrates efficacy in eye ointments for treating minor eye and eyelid infections.
Transparency
Dusting Analysis
The Formula
Formulation
Safety
Safety Profile
No dedicated CIR or SCCS cosmetic safety assessment was found; however, its use in medical eyedrops implies regulatory acceptance for topical antimicrobial applications. It is classified as an antimicrobial in EU cosmetic inventories.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Valuable for its potent bacteriostatic and preservative properties, though further cosmetic-specific safety and efficacy data for broader skin applications would enhance its profile.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources